Companion diagnostic testing for targeted cancer therapies: an overview

scientific article published on 10 April 2013

Companion diagnostic testing for targeted cancer therapies: an overview is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/GTMB.2012.0510
P698PubMed publication ID23574530

P2093author name stringYao-Shan Fan
P2860cites workMelanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationQ24629474
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancerQ27851440
Mutations of the BRAF gene in human cancerQ27860760
P433issue7
P304page(s)515-523
P577publication date2013-04-10
P1433published inGenetic Testing and Molecular BiomarkersQ15753742
P1476titleCompanion diagnostic testing for targeted cancer therapies: an overview
P478volume17

Reverse relations

cites work (P2860)
Q37651691A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.
Q27027560Clinical advances in molecular biomarkers for cancer diagnosis and therapy
Q39980317Cost Implications of Value-Based Pricing for Companion Diagnostic Tests in Precision Medicine
Q33647681Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor
Q38137281Endoscopic ultrasound-guided tissue acquisition
Q38635859Prediction-Oriented Marker Selection (PROMISE): With Application to High-Dimensional Regression.
Q36635960The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer Medicine

Search more.